KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Revenue (2020 - 2025)

Organon (OGN) has 6 years of Revenue data on record, last reported at $1.5 billion in Q4 2025.

  • For Q4 2025, Revenue fell 5.34% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $6.2 billion, down 2.92%, while the annual FY2025 figure was $6.2 billion, 2.92% down from the prior year.
  • Revenue reached $1.5 billion in Q4 2025 per OGN's latest filing, down from $1.6 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.6 billion in Q1 2024 and bottomed at $1.5 billion in Q4 2022.
  • Average Revenue over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2022.
  • Peak YoY movement for Revenue: fell 15.39% in 2021, then increased 7.61% in 2023.
  • A 5-year view of Revenue shows it stood at $1.6 billion in 2021, then fell by 7.36% to $1.5 billion in 2022, then increased by 7.61% to $1.6 billion in 2023, then fell by 0.38% to $1.6 billion in 2024, then decreased by 5.34% to $1.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.